IV. SEATS ARE AVAILABLE IN THE FOLLOWING DEPARTMENTS:
Prospectus for July, 2023 session
6
Ph.D.
A. SUMMARY/NUMBER OF SEATS: S. No. Department Seatsavailableto allcandidates. Theseseatshave FundsAvailable intheProject (FA) Seatavailable onlytocandidates whohavetheir OwnGovernment Fellowship(OF) Total (FA+OF) 1Anatomy 1 4 5 2Biochemistry 0 2 2 3Biophysics 5 8 13 4Biostatistics 1 0 1 5Biotechnology 0 4 4 6CardiacBiochemistry(CNC) 1 1 2 7CommunityMedicine 1 0 1 8CommunityOphthalmology(RPC) 2 2 4 9Dermatology&Venerology 1 0 1 10Gastroenterology&HNU 2 0 2 11LaboratoryMedicine 1 2 3 12LaboratoryOncology 2 1 3 13MedicalOncology 4 5 9 14Microbiology 1 5 6 15Neurology 4 2 6 16NuclearMedicine 1 0 1 17Ophthalmology(RPC) 3 1 4 18OralMedicine&RadiologyCDER 1 0 1 19OralPathology&MicrobiologyCDER 1 0 1 20Pathology 1 2 3 21Pediatrics 2 1 3 22Pharmacology 9 2 11 23Physiology 2 4 6 24Plastic,Reconstructive&BurnsSurgery 2 0 2 25PreventiveOncology(IRCH) 1 0 1 26PreventiveOncology(NCIJhajjar) 1 1 2 27Psychiatry 3 4 7 28Psychiatry&NationalDrugDependence TreatmentCentre 2 1 3 29Radiology(IRCH) 1 0 1 30ReproductiveBiology 1 4 5 31Rheumatology 1 1 2 32StemCell 1 2 3 33SurgicalDisciplines 1 0 1 34TransplantImmunology& Immunogenetics 1 1 2 Total 61 60 121
B. DETAILS OF SEATS (DEPARTMENTS, CODE, NO. OF SEATS, RESEARCH PROJECTS, ETC.):
FA1
1 M.Sc.LifeSciences, M.Sc.MedicalAnatomy, M.Sc.MedicalPharmacology, Masters of Pharmacy (Pharmacology), MBBS, BDS
Two years of research experience, Upper age limit: upto 35 years
1 M.Sc.Anatomy, M.Sc.Biotechnology, M.Sc.MedicalBiotechnology, M.Sc.LifeSciences, M.Sc.Biochemistry
To study the role of cholinergictransmissionon the amyloid beta induced neurodegeneration and therapeuticinterventionsfor Alzheimer’sdisease
Cryo-Electron Microscope Imagingfacilityforbiological specimens (Cells and Tissue)
I-1551 ICMR
DBT
=
To study the role of cholinergictransmissionon the amyloid beta induced neurodegeneration and therapeuticinterventionsfor Alzheimer’sdisease
Understanding Intercompartmental cross talk between insulin sensitive andinsulinresistantobese andnon-obesephenotypes usingadiposetissue
DHR-1312
I-1475 ICMR
DHR OF4
BT-2180 DBT
7 Ph.D. Prospectus for July, 2023 session
SN Department Code No. No. of seat Qualification Required & Specific Eligibility Criteria Project Title Project Code Funding By
1 Anatomy (FA-1 / OF-4 = 5)
I-1475 ICMR
OF1
Development of Artificial Intelligence based models forpredictionofselfharm amongst the patients of Depression BT-2185
OF2 1 M.Sc.Nano-Science, M.Sc.Physics, M.Sc.Chemistry, M.Sc.LifeSciences, M.Sc.MedicalAnatomy,
M.Sc.LifeSciences, M.Sc.MedicalAnatomy, M.Tech.Nano-Science, M.Tech.Physics, M.Tech.Chemistry, M.Tech.LifeSciences M.Tech.MedicalAnatomy
ExternaldeliveryofCisplatin using Human Papilloma Virus (HPV 16) based nanocarriersfortreatmentof cervicalcancer
1 M.Sc.LifeSciences, M.Sc.MedicalAnatomy, M.Sc.MedicalPharmacology, Masters of Pharmacy (Pharmacology), MBBS, BDS
2 Biochemistry (FA-0 / OF-2
02) OF1 1 M.Sc.MedicalBiochemistry, M.Sc.Biotechnology, M.Sc.LifeSciences, M.Sc.Biochemistry
1 M.Sc.Lifesciences, M.Sc.Bioinformatics, M.Sc.Computationaland IntegrativeSciences, M.Sc.ComputationalBiology, M.Tech.Lifesciences, M.Tech.Bioinformatics, M.Tech.ComputationalBiology, IntegratedM.Tech.LifeSciences, M.S.Research(MasterofScience) (Lifesciences), M.PharmMasterofPharmacy, Pharm.D(DoctorofPharmacy), BS-MS(BachelorofScience, MasterofSciencedualdegree), M.D.Biochemistry, M.Sc.MedicalBiochemistry, M.B.B.S., M.V.Sc., MDS
FA1 1 M.Sc.Biophysics, M.Sc.Biotechnology, M.Sc.Microbiology, M.Sc.Biochemistry, M.Sc.LifeSciences
Numericalapproximationof reaction-specific disassociation constants fromtheconvexconeofa genericmetabolicnetwork
Exploring the structurefunctioninterrelationshipsof Type 1 and Type 2 Ribosome Inactivating proteins (RIPs) from Iris bulbsforanti-tumoractivity.
FA-2 1 M.Sc.LifeSciences, M.Sc.Biosciences, G-QuadruplexformingDNA Aptamers against human EGFR as an alternative therapeutic approach for epidermalcarcinomas
I-1575 ICMR
FA-3 1 M.Sc.Biophysics, M.Sc.Biotechnology, M.Sc.Biochemistry, M.Sc.LifeSciences, M.Sc.Zoology, M.Sc.Neuroscience
FA-4 1 M.Sc.Biophysics, M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.LifeScience
FA-5 1 M.Sc.Biophysics, M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.LifeScience
Deciphering the role of platelets in drug resistant epilepsy.
SERB-40 DSTSERB
Identificationofnoveldrug molecules against a lethal angioinvasive disease, mucormycosis
Structural and Functional Studies of Mycobacterial Toxin-antitoxinsystems
I-1547 ICMR
I-1565 ICMR
SERB-16
Must have GATE/NET(LS)
Identifyingdysregulationof miRNAsandtheirtargetsin idiopathic recurrent pregnancyloss.
SERB OF1 1 M.Sc.Bioscience, M.Sc.LifeScience, M.Sc.Biotechnology, M.Sc.Biophysics, M.Sc.Biochemistry, M.Tech.Biotechnology
for
8
Ph.D. Prospectus
July, 2023 session OF2
SERB-24 SERB
3 Biophysics (FA-5 / OF-8 =13)
DST-
I-1430 ICMR
OF-2 1 M.Sc.Biophysics, M.Sc.Microbiology, M.Sc.Biotechnology, M.Sc.Biochemistry, M.Sc.BiologicalSciences, M.Sc.LifeSciences`
OF-3 1 M.Sc.Biophysics, M.Sc.Lifesciences, M.Sc.Chemistry, M.Sc.Biotechnology, M.Sc.Biochemistry
OF-4 1 M.Sc.Biophysics, M.Sc.Biotechnology, M.Sc.LifeScience, M.Sc.Chemistry, M.Sc.Microbiology, M.Sc.Bioengineering, M.Sc.Biochemistry, M.Sc.Bioscience, M.Sc.Pharmacology, M.Pharmacology, MSPharm.
OF-5 1 M.Sc.Biophysics, M.Sc.Biotechnology, M.Sc.LifeScience, M.Sc.Chemistry, M.Sc.Microbiology, M.Sc.Bioengineering,
Designing Novel Inhibitory Molecules for Quorum sensing in Gram negative bacteria
Screening of green tea antioxidants to reactivate anti-cancer activity of mutantp53inbreastcancer celllines
Mechanistic Understanding ofParkinson'sdiseaseand developing an early screeningmethod
Development of exosomebaseddrugdeliverysystem fornaturallyinspirednovel multifunctional neuroprotective molecules and their biological evaluation in Alzheimer’s
I-1545
Deciphering the role of platelets in drug resistant
M.Sc.LifeSciences, M.Sc.Zoology, M.Sc.Neuroscience, M.Pharmacy(Pharmacology), M.TechBiotechnology
OF-7 1 MScBiophysics, M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.LifeSciences,
Identificationofnoveldrug molecules against a lethal angioinvasive disease, mucormycosis
Structural and Functional studies of Mycobacterial Toxin-Antitoxinsystems
I-1565 ICMR OF8 1 M.Sc.Biophysics, M.Sc.Biochemistry, M.Sc.Microbiology, M.Sc.Biotechnology, M.Sc.LifeSciences, M.ScBiomedicalsciences
FA1 1 M.Sc.Statistics, M.Sc.Biostatistics
Developmentoflongitudinal growth reference and assessment of growth velocity, cardiometabolic measuresanditscorrelation among children in India-A prospectivestudy
I-1365 ICMR
9 Ph.D.
Prospectus for July, 2023 session
ICMR
I-1550
I-1488 ICMR
DHR-1332 DHR
ICMR
I-1547 ICMR
SERB-16 DSTSERB 4 Biostatistics (FA-1 / OF-0 =1)
To investigate the therapeutic potential of probioticsintreatmentand management of osteoporosis: Role of regulatoryBcells(Bregs)
To elucidate the immunomodulatory role of probiotics in modulating bone health in postmenopausal osteoporosis viaitseffectonILC3-ILCreg
of augmentation of intracellularBH4levels,by GTPCH-1genetransfer,on nitricoxidesynthaseactivity, protein levels and dimerizationinECFCsfrom CADpatientsanditseffect onECFCfunctionality
10 Ph.D. Prospectus for July, 2023 session 5 Biotechnology (FA-0 / OF-4 =4) OF1 1 M.Biotechnology,
M.Sc.Biotechnology, M.Sc.Biochemistry, M.Sc.BiomedicalSciences, M.Sc.Microbiology, M.Sc.Genetics, M.Sc.MolecularBiology, M.Sc.BiologicalSciences, M.Sc.LifeSciences, M.Sc.Zoology
I-1533 ICMR OF2 1 M.Biotechnology,
M.Sc.Biochemistry,
M.Sc.Biotechnology,
M.Sc.BiomedicalSciences, M.Sc.MolecularMedicine, M.Sc.Microbiology, M.Sc.Genetics, M.Sc.MolecularBiology, M.Sc.BiologicalSciences, M.Sc.LifeSciences, M.Sc.Zoology
BT-2189 DBT OF3 1 M.Sc.Biotechnology,
cellaxis
M.Sc.MolecularBiology, M.Sc.LifeSciences, M.Sc.Biochemistry, M.Sc.Genetics, M.Sc.Microbiology, Mechanistic analysis of tRNA fragments in DENV (Dengue Virus) pathogenesis
M.Sc.Genetics,
InvestigationofKeysplicing eventsmodulatedinDENV BT-2184 DBT 6 Cardiac Biochemistry (CNC) (FA-1 / OF-1 = 2) FA1
Tostudytheassociationof
in
I-1500 ICMR OF1 1 M.Sc.LifeSciences
I-1548 ICMR 7 Community Medicine (FA-1 / OF-0 = 1) FA1 1 M.Sc.HomeScience(Foods& Nutrition) Driversofreductionin anemiainIndia:Insights fromsubnationalexemplars N-2338 IAVI
SERB-41 SERB
M.Sc.Microbiology, M.Sc.Biosciences, M.Sc.Zoology, M.Sc.Virology, M.Sc.Bioinformatics
1 M.Sc.LifeSciences
circulating Endothelial ProgenitorCells(EPC)with Intrinsic Capacity (IC)
olderadults
Effect
FA1 1 M.Tech. Computer Sciences & Engineering, ME Computer Science & Engineering, M.TechInformationTechnology, M.E.InformationTechnology, MasterinPublicHealth(MPH) M.Sc.Optometry
With four years experiences in relevant field
symptomsandpre-existing health impairments in individuals aged 18 years and older who have recoveredfromCOVID-19
FA2 1 MDOphthalmology, MDCommunityMedicine, DiplomainOphthalmology, MastersinPublicHealth(MPH), MBBSwithMastersinPublic Health(MPH) DiplomainOphthalmology
1 M.Sc.Optometry, M.Sc.OccupationalTherapy, M.Sc.Nursing, MastersinPublicHealth(MPH)
AssessmentofPostCOVID symptomsandpre-existing health impairments in individuals aged 18 years and older who have recoveredfromCOVID-19
with one year of experience Operational Research on Developing Disability Inclusive Disability Eye N-1714 CBM Trust, Bangalore
N-1714 CBM Trust, Bangalore OF1 FA1
1 M.Sc.Biotechnology
1
qualified
of wheat with low
11 Ph.D. Prospectus
July, 2023 session 8 Community Ophthalmology
for
(RPC) (FA-2 / OF-2 = 4)
I-1391 ICMR
AssessmentofPostCOVID
I-1391 ICMR OF2
Diploma in Ophthalmology with one year of experience MDOphthalmology,
Operational Research on Developing Disability Inclusive Disability Eye Health 9 Dermatology & Venerology (FA-1 / OF-0 = 1)
1
I-1442 ICMR 10 Gastroenterology (FA-2
OF-0
CareinPancreaticDiseases I-1054 ICMR FA2
M.Sc.LifeScience NET/GATE
Explorationfordevelopment
Two years of research experience and upper age limit: 35 yrs as per ICMR SRF criteria immunogenicgluten
Morphological pattern of skin lesions in different complementationgroupsin children with xeroderma pigmentosum and its correlation with various cutaneous and extracutaneous cancers and photoaging N-1558
/
= 2) FA1 1 M.Sc.Biotechnology, M.Sc.Biochemistry, M.Sc.MedicalBiochemistry, M.Sc.LifeSciences, M.Sc.Nutrition, M.Sc.Microbiology, MBBS
ICARIndian Instituteof Rice Research
2 years research experience and upper age limit: upto 35 yrs as per ICMR SRF criteria)
Evaluation of the role of vitamin D receptor polymorphisms on the efficacyofcalcitrioltherapy in stage 3 to 5 chronic kidney disease: a prospectivestudy
role
12 Ph.D. Prospectus
July,
session 11 Laboratory Medicine (FA-1 / OF-2 = 3)
for
2023
FA1 1 M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.BiomedicalSciences
I-1338 ICMR OF1 1 M.Sc.Biotechnology,
M.Sc.Chemistry, M.TechBiotechnology
HBV
I-1346 Bigtech Bangalore OF2 1 M.Sc.Biochemistry,
I-1338 ICMR 12 Laboratory Oncology (FA-2 / OF-1 = 3) FA1 1 M.Sc.LifeSciences
upto 30 yrs)
I-1472 ICMR FA2 1 M.Sc.Lifesciences, M.Sc.Biochemistry, M.Sc.Biotechnology Identification and characterizationofcellfree nucleicacidbasedmarkers for early detection and predictionofrelapseinAML DHR-1329 Departme ntof Health Research Study of expression, function and clinical sigificanceofDNAdamage repairpathwaygenesinALL I-1472 ICMR 13 Medical Oncology (FA-4 / OF-5 = 9) FA1 1 M.ScLifeSciences JRF position as per ICMR norms Estimationoftheprevalence of Epstein Barr virus positivity in aggressive mature B-Non-Hodgkin lymphoma in the Indian subcontinent and deciphering the genetic basis of its impact on diseasebiologyandsurvival I-1568 ICMR FA2 1 M.Sc.LifeSciences M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.StemCellTechnology andRegenerativeMedicine, M.Sc.Microbiology, M.Sc.Zoology, M.Sc.Immunology, M.Sc.Genetics, M.Tech.Biotechnology M.Tech.Bioinformatics M.Tech.Bioengineering MTechBiomedicine A comparative analysis of
StemCells(MSCs)derived fromdifferentsources,with
immunosuppressive
I-1492 ICMR
M.Sc.Biochemistry,
Rapiddiagnosticevaluation of micro PCR for
quantification
M.Sc.Biotechnology, M.Sc.BiomedicalSciences Evaluation of the
of vitamin D receptor polymorphisms on the efficacyofcalcitrioltherapy in stage 3 to 5 chronic kidney disease: a prospective double-blind study
2 year research experience and upper age limit:
Study of expression, function and clinical sigificanceofDNAdamage repairpathwaygenesinALL
secretomeofMesenchymal
a focus on
potentialinAcuteGVHD
FA3 1 M.Sc.LifeSciences, M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.StemCellTechnology andRegenerativeMedicine, M.Sc.Microbiology, M.Sc.Zoology, M.Sc.Immunology, M.Sc.Genetics, M.Sc.BasicSciences
M.Sc.Clinical
Upper age limit: upto 30 years
FA4 1 M.Sc.Biotechnology, M.Sc.Microbiology, M.Sc.Biosciences, M.Sc.LifeSciences, M.Sc.Genetics, M.Sc.Zoology
sorafenib on cognition, cardiovascular and reproductive functions in patientswithfibromatosis
N-2348
Evaluating the theranostic potential of canonical and non canonical WNT signaling in Gallbladder Cancer
OF1 1 M.Sc.LifeSciences Decoding mitochondrial heterogeneity and deciphering potential therapeutic targets in pediatric acute myeloid leukemia
OF2 1 M.Sc.Biotechnology, M.Sc.Biochemistry, M.Sc.LifeSciences,
OF3 1 M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.Microbiology, M.Sc.Zoology, M.Sc.Genetics, M.Sc.Biosciences, M.Sc.LifeSciences
ElucidationofMolecular mechanismofoncogenesis mediatedbyUbiquitin specificpeptidase37 (USP37)anditstherapeutic potentialinprostatecancer
DevelelopmentofBCMA basedChimericantigen receptorT(CART)cellin MultipleMyeloma
I-1546 ICMR
OF5 1 M.Sc.Microbiology, M.Sc.LifeSciences, M.Sc.Biotechnology, M.Sc.Biochemistry, M.Sc.Zoology, M.Sc.MolecularBiology
"APP-DIP:Developmentof AI based prognostic platform for an early detection of infection in immune compromised patients"
I-1514 ICMR
DHR-1316 Departme ntof Health Research (DHR) India
I-1560 ICMR
BT2187 DBT
BT-2190 DBT
13
Ph.D. Prospectus for July, 2023 session
Toseetheearlyeffectof DESMOID TUMOR RESEAR CH FOUNDA TION
EstrogenRelatedReceptor Gamma (ERRγ) as a potential biomarker and therapeutictargetforhuman colorectal cancer and to investigate the antitumor efficacy of GSK5182 (Estrogen Related Receptor-γinverseagonist) incombinationwithMK2206 (a novel Akt inhibitor) in coloncancerinvivo
OF4 1 M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.Microbiology, M.Sc.Zoology, M.Sc.Genetics, M.Sc.Biosciences, M.Sc.LifeSciences
14 Ph.D. Prospectus for July, 2023 session 14 Microbiology (FA-1 / OF-5 = 6) FA1 1 M.Sc.Microbiology, M.Sc.Biotechnology, M.Sc.LifeSciences
Research Fellow- 2 Years research experience after M.Sc. Exploring SELEX technology for potential POCT development for Genital Chlamydia trachomatis I-1411 ICMR OF1 1 M.Sc.Microbiology Multi-centric study on prevalenceofMycoplasma genitaliumanditsresistance markers in the high–risk group (MSM and FSW) attending sexually transmitted disease clinics inNorthIndia I-1348 ICMR OF2 1 M.Sc.MedicalMicrobiology, M.Sc.Biotechnology National Program for Surveillance of Viral Hepatitis N-1981 National Centrefor Disease Control (NCDC), NewDelhi (MoHFW) OF3 1 M.Sc.Microbiology, M.Sc.Biotechnology Site-specific biomarkers to differentiate infection from eithercolonizationoraseptic inflammationinICU I-1460 ICMR OF4 1 MScMicrobiology MolecularEpidemiologyand In-Vitro Antifungal Susceptibility of Cryptic Aspergillus species from Clinical and Environment I-1439 ICMR Expanded viral etiological investigationofgenitalulcer disease with phenotyping andgenotypingforantiviral drug resistance in herpes simplexviruses I-1480 ICMR 15 Neurology (FA-4 / OF-2 = 6) FA1 1 MD, MDS, MS, DNB Upper age limit: 35years Can capacity building at primarycarelevelimprove accesstoepilepsycarein Chhattisgarh? An ImplementationResearch I-1321 ICMR FA2 1 MBBS, MPH, MD, MS Clinical Research Training Program Fellowship Scaling-upThe CompetencyofPrimary CareWorkerstoManage EpilepsybyTask-Sharing (STOP-Epilepsy) BT-2194WT DBT/Welc omeTrust Grant India Alliance FA3 1 MBBS, MPH, MD, MS Clinical Research Training Program Fellowship Scaling-upThe CompetencyofPrimary CareWorkerstoManage EpilepsybyTask-Sharing (STOP-Epilepsy) BT-2194WT DBT/Welc omeTrust Grant India Alliance
Senior
M.Sc.Biochemistry, M.Sc.Pharmacology, M.Sc.SpaceBiology, M.Sc.MolecularBiology, M.Tech.Biotechnology, M.Tech.Aerospace, M.Tech.Aeronautics
2-Year
15 Ph.D. Prospectus for July, 2023 session FA4 1 M.Sc.LifeSciences, M.Sc.Biotechnology, MBBS Werableelectronicsfor swallow-graphyinstroke patients AI-47 AIIMS-IIT Delhi collaborati veproject OF1 1 M.Sc.LifeSciences, MBBS EfficacyandSafetyof InjectionTenecteplasein 4.5to24hoursimaging eligiblewindowpatients withAcuteIschemicStroke SERB-23 SERB, DST, Governme ntofIndia OF2 1 M.Sc.LifeSciences M.Sc.AppliedScience Evaluationofeffectsof repetitivetranscranial magneticstimulation(rTMS) atsupplementarymotor area(SMA)inParkinson’s Disease(PD)patientswith freezingofgait(FOG)-A RandomisedSham ControlledStudy I-1256 ICMR, NewDelhi 16 Nuclear Medicine (FA-1 / OF-0 = 1) FA1 1 M.Sc. Nuclear Medicine Technology, Diagnostic Accuracy of 68GaPSMA-11PET/CTand Conventional Imaging for Initial Staging of Intermediate and High-risk Prostate Cancer Patients (thePROCAstudy. N-2247 IAEA (Internatio nalAtomic Energy Agency),V ienna,Aust ria 17 Ophthalmology (RPC) (FA-3 / OF-1 = 4) FA1 1 MSc.LifeScience, M.Sc.Optometry, M.Sc.Biotechnology Differentiation, molecular characterization and translation application of culture expanded human cornealendothelialcells I-1522 ICMR Indigenousvisualacuitytest forpreverbalchildren AI-57 AIIMS M.Sc.Optometry,
Experience - SRF Post available in the Project ToEvaluatetheClinical UtilityofTearBiomarkers forEarlyDetectionof KeratoconususingaMass Spectrometry-based ProteomicApproach I-1462 ICMR OF1 1 M.ScBiotechnology, M.Sc.Bioinformatics, M.Sc.Optometry, M.Sc.Biochemistry, M.Sc.Pharmacology, M.Sc.SpaceBiology, M.Sc.MolecularBiology, M.Tech.Biotechnology, M.Tech.Aerospace, M.Tech.Aeronautics ToEvaluatetheClinical UtilityofTearBiomarkers forEarlyDetectionof KeratoconususingaMass Spectrometry-based ProteomicApproach I-1462 ICMR 18 Oral Medicine & Radiology CDER (FA-1 / OF-0 = 1) FA1 1 MDSOralMedicineandRadiology, MDSOralPathology, MDSPublicHealthDentistry, “Designanddevelopmentof a safe, portable, economical, non-invasive, I-1535 ICMR
19 Oral Pathology & Microbiology
CDER (FA-1 / OF-0 = 1)
MBBSwithpostgraduatediploma inmedicalsubject, BDSwithpostgraduatediplomain medicalsubject
MBBS,BDS
-MDSwithoneyearexperience
-MBBS/BDSwithpostgraduate diplomainmedicalsubjectand twoyearsexperience
-MBBS/BDSwithfouryears experienceinmedicalsubject.
Upper age Limit: upto 40 years
FA1 1 MDSOralPathologyMicrobiology
PointofCaredigitalinfrared imaging system for screening and early detectionoforalcancer:An exploratorypilotstudy”
Multiregion sequencing to unveil the intratumoral heterogeneity and novel biomarkers in oral squamouscellcarcinomain anIndianpopulation:Case ControlStudy
I-1524 ICMR
20 Pathology (FA-1 / OF-2 = 3)
FA1 1 M.Sc.LifeSciences
Upper age limit: upto 32 yrs
Toinvestigatethemetabolic perturbationsinEndometrial Cancer by targeted transcriptomicsapproachin Indiancohort
Clinicopathological correlation and amyloid subtyping in cases of cardiac amyloidosis: An observationalstudy
Evaluation of specific molecular alterations and tumor immune microenvironment for detection of clinically actionable targets in high grade salivary gland carcinomas
I-1471 ICMR
I-1563 ICMR
I-1465 ICMR
21 Pediatrics (FA-2 / OF-1 = 3)
FA1 1 M.Sc.Biotechnology, M.Sc.MedicalBiotechnology
Should have 2 years research experience
Identification of potential pathogen(s) among neonates with culturenegativesepsis
BT-2171 DBT
FA2 1 MScGenetics, M.Sc.HumanGenetics, M.Sc.Biotechnology, M.Sc.LifeSciences
Deciphering the complexities of apparently balanced chromosomal rearrangements associated withclinicalphenotypesby wholegenomesequencing
Deciphering the complexities of apparently balanced chromosomal rearrangements associated withclinicalphenotypesby wholegenomesequencing
Ph.D. Prospectus for July, 2023 session
I-1481 ICMR
I-1481 ICMR OF1 1 MScGenetics, M.Sc.HumanGenetics, M.Sc.Biotechnology, M.Sc.LifeSciences
16
FA1 1 M.Sc.Pharmacology, M.Sc.LifeSciences
M.Sc. with 2 years experience
MBBS BDS MastersofPharmacy (Pharmacology)
Eligibility of Project Associate II of DHR/ SRF of ICMR
FA2 1 M.Sc.Pharmacology, M.Sc.LifeSciences, MDPharmacology, MDMedicine, MDPhysiology, Masters of Pharmacy (Pharmacology)
BDS
3 years research experience and Upper age limit: upto 40 years
FA3 1 M.Sc.Pharmacology, M.Sc.LifeSciences, MDPharmacology, MDMedicine, MDPhysiology,
Correlation of antidepressanttherapywith orexinergic pathway integrating targeted metabolomics in patients with major depressive disorder: a longitudinal study
CorrelationofgermlineHLA variationbynextgeneration sequencing with immune related adverse events in cancerpatients
SERB-37 SERB
Toevaluatetheanticancer activityofivermectinwith gefitinibinepidermalgrowth receptormutatedlung cancercelllineand xenograftmousemodel
I-1527 ICMR
FA4 1 M.Sc.Pharmacology, M.Sc.LifeSciences, MDPharmacology, MDMedicine, MDPhysiology, Masters of Pharmacy (Pharmacology)
BDS
Upper age limit: upto 30 years
FA5 1 M.Sc.Pharmacology, M.Sc.LifeSciences, M.Pharmacy, M.Tech.(Biotechnology), MDPharmacology, MVSc, MS(Pharm), PharmD
FA6 1 M.Sc.Pharmacology, M.Sc.LifeSciences, M.Pharmacy, M.Tech(Biotechnology), MDPharmacology, MVSc, MS(Pharm), PharmD
Chemotherapeuticeffectof aselectedUnaniMedicinein xenograftmousemodelof lungcancer
N-2318 Central Council for Research inUnani Medicine
Anemia:Exploringtherole of vitamin D, essential elements and lifestyle in Indianpopulation
I-1427 ICMR
Anemia:Exploringtherole of vitamin D, essential elements and lifestyle in Indianpopulation
I-1427 ICMR
17
22 Pharmacology (FA-9 / OF-2 = 11)
Ph.D. Prospectus for July, 2023 session
DHR-1509 DHR
FA7 1 M.Sc.Pharmacology, M.Sc.LifeSciences, M.Pharmacy, M.Tech(Biotechnology), MDPharmacology, MVSc, MS(Pharm), PharmD
FA8
1 M.Sc.Pharmacology, M.Sc.LifeSciences, M.Pharmacy, M.Tech(Biotechnology), MDPharmacology, MVSc, MS(Pharm), PharmD
FA9 1 M.Sc.Pharmacology, M.Sc.Psychology, M.Sc.Psychiatry, M.Sc.Neurology, M.Sc.LifeSciences, MasterofPharmacy, MBBS, BDS
Upper age limit: 35 years
DesignandDevelopmentof Wirelessly Powered Nanoscale Integrated AntennaEnabledLeadless CardiacPacemakerSystem for Wireless Monitoring of HeartHealth
Evaluation of the cardioprotective effect of remote ischaemic preconditioning in acute coronarysyndromepatients and its correlation with vitaminD
Genetic expression of monoaminergic neurotransmission related polymorphisms and their association with antidepressantresponsein Indian patients suffering fromdepression
Anemia:Exploringtherole of vitamin D, essential elements and lifestyle in
OF2
1 M.Sc.Pharmacology, M.Sc.Psychology, M.Sc.Psychiatry, M.Sc.Neurology, M.Sc.Lifesciences, MasterofPharmacy, MBBS, BDS
FA1 1 M.Sc.Physiology, M.Sc.LifeSciences, M.Sc.Zoology, M.Sc.Nursing, M.Biotechnology, MastersinPhysiotherapy, M.Pharmacy, MDPhysiology
Upper age limit: upto 30 years and 3 years age relaxation for OBC candidates and 5 years relaxation for SC/ST candidates
FA2 1 M.Sc.Physiology, M.Sc.Biochemistry, M.Sc.Biotechnology, M.ScBiomedicalSciences
Genetic expression of monoaminergic neurotransmission related polymorphisms and their association with antidepressantresponsein Indian patients suffering fromdepression
Functionalandbiochemical assessment of cardiovascular sequelae in COVID-19survivorsandits associationwithimbalance in Renin Angiotensin Aldosterone pathway: an observationalstudy
Nuclear factor kappa B activation,Hypoxiainducible Factor-1andinducibleNitric OxideSynthaseexpression
18
Ph.D. Prospectus for July, 2023 session
I-1556 ICMR
DHR-1496 DHR
I-1331 ICMR
I-1427 ICMR
I-1331
23 Physiology
/ OF-4 = 06)
ICMR
(FA-2
I-1539 ICMR
I-1559 ICMR
25 Preventive Oncology (IRCH)
(FA-1 / OF-0 = 1)
Upper age limit: upto 35 years
OF1 1 M.Sc.Physiology, M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.LifeSciences, MBBS
OF2 1 M.Sc.Physiology, M.Sc.LifeSciences, M.Sc.Zoology, M.Sc.Nursing, M.Biotechnology, M.Tech.ComputerScience, M.Tech.Electrical-Electronics, M.Tech.BiomedicalEngineering, M.Pharmacy, MDPhysiology,
OF3 1 M.Sc.Physiology, M.Sc.LifeSciences, M.TechBiotechnology
in human vascular endothelialcellsbyserumof adults with Obstructive SleepApnea
D-618
26 Preventive Oncology (NCI Jhajjar)
1 M.Sc.Biotechnology, M.Sc.Pharmacology, M.Sc.Microbiology, M.Sc.HumanBiology
FA1 1 M.Sc.LifeSciences,
Upper age limit: upto 30 years and relaxation to reserved category candidate as per the government norms
FA1 1 M.Sc.LifeSciences, M.Sc.Bioinformatics, M.Sc.ComputerSciences, MASocialSciences, MasterinMedicalSocialWork (MSW), MBBS
ARTSENS® Age : A multimodal method & system for reliable assessment of vascular ageing associated early health markers in routine clinical practice for early screening & timely intervention
“Neuralmechanismofsleep deprivation induced metabolicchangesinrats”
Geneexpressionprofilingby RNA Seq and metabolic signatures in
post
SERB-33 Science and Engineeri ng Research Board (SERB)
I-1557 ICMR
Development Of A Novel Cancer Immunotherapeutic Agent By Incorporating Cancer/Testis Antigen NyEso-1 Into Mycobacterium Indicus Pranii And EvaluationOfItsAntitumor Efficacy And Immune Mechanisms Using Mouse ModelOfTumor
Assessment of Breast cancer risk profile and factorsimplicitindifferential incidencerateswithinrural and urban populations in India by developing a machinelearning-basedrisk predictiontool
Ph.D. Prospectus for July, 2023 session
SERB-26 SERB
I-1486 ICMR
19
Efficacy of a yogameditation based lifestyle interventioninpatientswith obesity and major depressive disorder: a randomisedcontrolledtrial DST/SAT YAM
COVID PulmonaryFibrosis I-1374 ICMR 24 Plastic, Reconstructive & Burns Surgery (FA-2
OF-0 =
I-1520 ICMR OF4 1 M.Sc.Physiology, M.Sc.BiomedicalSciences, M.Sc.Zoology, M.Sc.Biotechnology, M.Sc.Biochemistry
/
2)
I-1558 ICMR FA2
Post Burn Scars and Contractures: A Hospital basedstudyoftheburdenof disease,socioeconomicand clinicalfactorsaffectingthe outcome, and steps to mitigatethem
Prevalence of Cyanide Poisoninginvictimsofburn injuries-aHospitalbased study
(FA-1 / OF-1 = 2)
M.Sc. or Master with Two years research experience
MBBS with three years of research experience OR
MDCommunityMedicine, MDPreventive&SocialMedicine, MasterinPublicHealth(MPH), M.Tech.ComputerSciences& Engineering(CSE), M.Tech.InformationTechnology, MEComputerSciences& Engineering(CSE), M.E.InformationTechnology,
Upper age limit: upto 35 years with relaxation to reserved categories as per govt. rules
Effectoftranscranialdirect currentstimulationtDCSon cognitive function, symptomsandfunctioningin children and adolescents with attention deficit hyperactivity disorder ADHD: A Randomized ControlledStudy
Ph.D. Prospectus for July, 2023 session
20
OF1
(MSW) MDCommunityMedicine MBBS Assessment of Breast cancer risk profile and factorsimplicitindifferential incidencerateswithinrural and urban populations in India by developing a machinelearning-basedrisk I-1486 ICMR 27 Psychiatry (FA-3 / OF-4 = 7) FA1 1 M.A.Psychology, M.A.ClinicalPsychology, M.Sc.Psychology, M.Sc.ClinicalPsychology, Early Detection and Rehabilitation of Neurocognitive and PsychoBehavioural Deficits in Children with Cancers: DevelopmentofaScreening
and a Double-blind RandomizedControlStudy I-1564 ICMR FA2 1 M.Phil.(ClinicalPsychology) AstudytoexaminePsychoSocial and Behavioral Domains among School
Adolescents
Covid-19Pandemic:Mixed study I-1404 ICMR FA3 1 M.A.Psychology, M.A.ClinicalPsychology, M.A.AppliedPsychology, M.A.CounselingPsychology, M.Sc.Psychology, M.Sc.ClinicalPsychology, M.Sc.AppliedPsychology, M.Sc.CounselingPsychology,
M.Phil.RehabilitationPsychology
1 M.Sc.LifeSciences, M.Sc.Bioinformatics, M.Sc.ComputerSciences, MASocialSciences, MasterinMedicalSocialWork
Scale
going
during
M.Phil.ClinicalPsychology
D-632 DST
21 Ph.D. Prospectus for July, 2023 session M.A./M.Sc. with 2 years experience OF1 1 M.A.Psychology, M.A.ClinicalPsychology, M.Sc.Psychology, M.Sc.ClinicalPsychology DevelopmentofaBi-Lingual Mobile-app based NeuroCognitiveScreeningtoolfor early identification of children aged 3-11 years withAutismandASDComorbidwithADHD I-1515 ICMR OF2 1 M.A.Psychology, M.A.ClinicalPsychology, M.Sc.Psychology, M.Sc.ClinicalPsychology, Early Detection and Rehabilitation of Neurocognitive and PsychoBehavioural Deficits in Children with Cancers: DevelopmentofaScreening Scale and a Double-blind RandomizedControlStudy I-1564 ICMR OF3 1 M.Phil.ClinicalPsychology AstudytoexaminePsychoSocial and Behavioral Domains among School going Adolescents during Covid-19Pandemic:Mixed study I-1404 ICMR OF4 1 M.Sc.Psychology Arandomizedcontrolledtrial of the effectiveness of TranscranialDirectCurrent Stimulation (tDCS) for treatment of major AI-55 AIIMS-IIT Collaborat ive Research Grant 28 Psychiatry & National Drug Dependence Treatment Centre (FA-2 / OF-1 = 3) Development of a toolfor identification,diagnosisand earlyinterventionformental disorders among persons withaddictivedisorders DHR1542 DHR, ICMR FA2 1 M.A.SocialWork, M.A.ClinicalPsychology M.Sc.SocialWork, M.Sc.ClinicalPsychology 3 years experience in research/teaching and design and development Atimeseriesapproachto evaluating the role of cooccurring depression and anxietyasdeterminantsof treatment outcome, disabilityandqualityoflife amongpatientswithopioid dependence I-1521 ICMR OF1 1 M.A.SocialWork, M.A.ClinicalPsychology, M.Sc.SocialWork, M.Sc.ClinicalPsychology Atimeseriesapproachto evaluating the role of cooccurring depression and anxietyasdeterminantsof treatment outcome, disabilityandqualityoflife amongpatientswithopioid dependence I-1521 ICMR 29 Radiology (IRCH) (FA-1 / OF-0 = 1) FA1 1 MBBS, B.Tech.ComputerScience Useofartificialintelligence todetectbreastcanceron mammogramanditsusein theIndianpopulation BT-2060 Departme ntof Biotechnol ogy 30 Reproductive Biology (FA-1 / OF-4 = 5) FA1 1 M.Sc.ReproductiveBiology, M.Sc.Zoology, M.Sc.Biotechnology, M.Sc.Biochemistry, Effect of semen cryopreservation on sperm telomere biology and fertilizationpotential I-1452 ICMR
M.Sc.Anatomy, M.Sc.Physiology, M.Sc.LifeSciences, M.B.B.S, MasterofVeterinary Science(MVSc.)
M.Sc.with2yearsresearch experienceandUpperagelimit: upto35years
An investigation on underlying mechanism of PCOS in association with endocrine disrupting chemicals(BisphenolAand advanced
To study the mechanisms underlyingthepathogenesis ofPre-eclampsia
Anopen-label,multi-center protocol for patients who havecompletedaprevious Novartis sponsored Secukinumabstudyandare judgedbytheinvestigatorto benefit from continued Secukinumab treatment.
Anopen-label,multi-center protocol for patients who havecompletedaprevious Novartis sponsored Secukinumabstudyandare judgedbytheinvestigatorto benefit from continued Secukinumab treatment. CAIN457A02001B
To investigate the role of humanmesenchymalstem cellderivedexosomesasa cell free therapeutic
Ph.D. Prospectus for July, 2023 session
22
OF1 1 M.Sc.ReproductiveBiology,
M.Sc.LifeSciences
M.Sc.Zoology,
Glycation End
BT-2191 DBT OF2 1 M.Sc.ReproductiveBiology,
M.Sc.LifeSciences,
(MVSc.)
products
M.Sc.Biotechnology, M.Sc.Biochemistry,
M.Sc.Genetics, M.Sc.Physiology, MasterofVeterinaryScience
I-1323 ICMR OF3 1 M.Sc.ReproductiveBiology, M.Sc.Zoology, M.Sc.Biotechnology, Effect of semen cryopreservation on sperm telomere biology and fertilizationpotential I-1452 ICMR M.Sc.ReproductiveBiology, M.Sc.LifeSciences Idiopathic SCOS : An investigation to find out epigenomicetiology I-1221 ICMR 31 Rheumatology (FA-1 / OF-1 = 2) FA1 1 M.Sc.LifeSciences M.Sc.Biotechnology M.Sc.Genetics M.Sc.Biochemistry
N-2291
OF1 1 M.Sc.LifeSciences M.Sc.Biotechnology M.Sc.Genetics M.Sc.Biochemistry
CAIN457A02001B
Novartis Pharmace uticlas
32 Stem Cell (FA-1 / OF-2) FA1 1 M.Sc.LifeSciences,
N-2291 Novartis Pharmace uticlas
M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.Microbiology,
BT-2195 DBT
Note:
M.Sc.Zoology, M.Sc.Immunology, M.Sc.Genetics, M.TechBiotechnology, M.TechBioinformatics, M.TechBioengineering, M.TechBiomedicine
To investigate the role of humanmesenchymalstem cellderivedexosomesasa cell free therapeutic approachforameliorationof symptoms of autism spectrumdisorders
approachforameliorationof symptoms of autism spectrumdisorders OF1 1 M.Sc.LifeSciences, M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.Microbiology, M.Sc.Zoology, M.Sc.Immunology, M.Sc.Genetics, M.TechBiotechnology, M.TechBioinformatics, M.TechBioengineering, M.TechBiomedicine
1 M.Sc.LifeSciences M.Sc.Biochemistry, M.Sc.Biotechnology, M.Sc.Microbiology, M.Sc.Zoology, M.Sc.Immunology, M.Sc.Genetics, M.Tech.Biotechnology, M.Tech.Bioinformatics, M.Tech.Bioengineering,
All seats in a department will be clubbed.
An observational study to evaluatetheroleofimpaired NAD+ biosynthesis in calf skeletalmuscledysfunction in people with peripheral
Candidates will be eligible ONLY for seats in the department that they have applied for.
Candidates will be allocated seats in order of their merit in the exam.
Candidates WITH their Own Government Fellowship (OF) can select from both OF and Fellowship Available (FA) seats (where they fulfil the eligibility criteria for the seat)
Candidates WITHOUT their Own Government Fellowship can select only Fellowship Available (FA) seats (where they fulfil the eligibility criteria for the seat)
Ph.D. Prospectus for July, 2023 session
23
BT-2195 DBT OF2
Scaffold for TissueRegeneration BT-2201 DBT 33 Surgical Disciplines (FA-1 / OF-0= 1
Development of Amniotic MembraneandNano-Fiber Composite
)
I-1573 ICMR 34 Transplant Immunology & Immunogenetics (FA-1 / OF-1= 2 ) Clinical Utility of Liquid BiopsyinCardiacAllograft Rejection I-1536 ICMR OF1
M.Sc.BiologicalSciences Clinical Utility of Liquid BiopsyinCardiacAllograft Rejection I-1536 ICMR
1
Successful candidates will be subjected to eligibility criteria of respective Project before admission.
Candidates who are allotted a seat but do not join or resign after joining will not be eligible for any additional rounds of seat allocation.
C.GENERAL ELIGIBILITY
Eligibility for Ph. D course (Open candidates)
A candidate seeking admission to the course of study leading to the award of a Degree of Doctor of Philosophy must possess at least one of the following qualifications:
A.
a). Medical qualification: MBBS/BDS with minimum 55% aggregate marks or MD/MS/MDS/DM/M.Ch. in the subject concerned or Diplomat of National Board of Examination. Candidates who have obtained any of these degrees from medical colleges which are not recognized by the Medical Council of India shall not be eligible to apply.
b). Nursing Qualification: Candidates holding M.Sc. degree with minimum 55% aggregate marks in Nursing Speciality will also be eligible for Ph. D admission in College of Nursing.
B. Non-Medical – For non-medical candidate’s eligibility shall be Master’s Degree (two year’s course) awarded by Indian Universities or equivalent in the subject as per requirement of the project.
Candidates holding M.Sc. (Other than M.Sc. Nursing) M.Tech. degree, BAMS & BHMS will be eligible for the Non-Medical Qualification Category. Candidate having eligibility under non-medical category should have at least 60% marks in the last eligibility examination qualified.
Candidate possessing Master’s Degree through distant learning course shall not be eligible.
(a) Special weightage for non-medical candidates:
(i) Candidateswho havequalifiedthebelow listedNational EntranceTests leadingtotheaward of a fellowship will be given special weightage in the entrance examination as detailed in method of selection part of guidelines. Such candidates should apply under the Own Fellowship (OF) categoryandupload proof of award of the qualifying fellowship inthe online form.
Joint CSIR-UGC NET for JRF
ICMR – JRF
ICMR- SRF
DBT – JRF
NBHM screening test
INSPIRE fellowship
(ii) To be eligible for special weightage marks, ALL the following criteria must be fulfilled:
1. The result of the above listed National Entrance Tests must have been declared between July 2021 and last date of application i.e. 16.08.2023.
2. The award of the fellowship must be based on the result of the above listed National Entrance Tests.
3. The fellowships should be tenable at AIIMS, New Delhi.
Ph.D. Prospectus for July, 2023 session
24
4. The letter of award of fellowship must be uploaded with the application form. Passing of the listed National Entrance Tests is not acceptable as proof of award of fellowship.
C. Eligibility for OF seats: To be eligible for OF seats, candidates must fulfil ANY of the following criteria:
1. Candidates who have qualified the National Entrance Tests leading to the award of a fellowship tenable at AIIMS AND are eligible for award of special weightage marks as provide in section B (a) above.
2. In-service or sponsored candidates who will receive their salary/stipend from the sponsoring/parent organization.
Note:
I. Candidates working under Central Govt./Semi Govt./Autonomous organization should submit their applications through proper channel i.e. employer. They will be required to submit a ‘No Objection Certificate” from their employer before they are allowed to join the Ph.D. Course.
II. Candidates who are likely to complete the requisite qualification and degree by 16.08.2023 may also apply. All such candidates must submit a certificate on the letterhead of the College/Universities, signed and stamped by the Registrar/Dean/Principal confirming that the candidate is likely to complete the eligibility qualification by 16.08.2023. This does not apply to claiming Own Fellowship (OF), proof of which must be submitted before the last date of submission.
III. Candidates who are completing their requisite qualification after 16.08.2023 are not eligible to take this examination.
IV. Completing the requisite qualification means that the final result of the qualifying exam must have been declared before the last date specified.
V. Applicants from AIIMS Faculty/Scientific Staff for Ph. D. registration will be considered as inservice candidates as per guidelines laid down by AIIMS in this regard.
VI. A candidate is allowed to submit application for one specialty/department only.
VII. “CSIR-Net qualified may also be given Special weightage in the entrance examination as detailed in method of selection part of guidelines on the basis of production of – Detailed Electronic Certificate or Award letter”.
D.DURATION OF THE COURSE
1. The duration of the course shall be the time period from registration to submission of thesis. The minimum period of registration in respect of all the candidates who are registered for Ph.D. shall be three years. The maximum period of registration shall not exceed five years. Extension beyond the period of 5 years can be given for a maximum period of 6 months on the recommendation of Dean Committee and final approval by Dean/Director.
2. Further extension beyond 5 years & 6 months can only be given by the Academic Committee for a maximum period of 6 months in highly exceptional circumstances (like medical exigencies, natural calamities etc.) and such extension may not be given retrospectively.
3. The Chief guide of Ph.D. Student shall give clear reason for the delay to the Academic Committee and must present the case before Academic Committee.
4. In case of extension beyond 6 years without justifiable reasons and circumstances as mentioned above, the Ph.D. registration of the candidate shall be cancelled.
5. Failure to submit thesis within stipulated time period of maximum 5yrs. with extension after approval upto 5½ years (6 years in exceptional circumstances by prior approval of Academic Committee) shall lead to cancellation of PhD registration of the candidate.
Ph.D. Prospectus for July, 2023 session
25
E. METHOD OF SELECTION
A: Selection for Ph.D. registration will be through a three-stage performance evaluation as under:
1. STAGES I and II:
a. Stage-I:30 Marks (30 MCQs of 1 Mark each) Aptitude related MCQs covering English(Written and verbal skills), Biostatistics, Research Methodology, Cell Biology, Lab Technology etc.
b. Stage-II:40 Marks (40 MCQs of 1 Mark each) Subject related theory based comprising Multiple Choice Questions (MCQs) of MD/MS/MDS/M.Sc. Entrance level.
Total Marks (Stage I + II): 70 (30+40)
Total Duration (Stage I + II): 90 Minutes
Eligibility for Stage-III: Candidates must score at least 35 marks in Stages I and II (Combined) to be eligible for Stage III. Candidates who do not fulfill the criteria to qualify for stage III will not be eligible for selection.
2. SPECIAL WEIGHTAGE:
A: Medical / Dental/ Nursing candidates
10 marks will be added to the total score of Stages I and II for candidates who fulfill both the following criteria:
(1) they are eligible for stage III
(2) they also hold a Medical Degree (MBBS/ BDS/ MDS/ DNB/ MD/ MS/ DM/ M.Ch.) or M.Sc. (Nursing) or equivalent.
B: Non-Medical candidates
10 marks will be added to the total score of Stages I and II for candidates who fulfill both the following criteria:
(1) They are eligible for stage III
(2) They also have qualified in any one of the following National Entrance Tests leading to the award of a fellowship tenable at AIIMS, New Delhi in the last 2 years (July 2021 to last date of application i.e. 16.08.2023):
Joint CSIR-UGC NET for JRF
ICMR – JRF
ICMR- SRF
DBT – JRF
NBHM screening test
INSPIRE fellowship
Such candidates should apply under the Own Fellowship (OF) category and upload proof of award of the qualifying fellowship in the online form. The fellowships should be tenable at AIIMS, New Delhi
To be eligible for special weightage marks, ALL the following criteria must be fulfilled:
Ph.D. Prospectus for July, 2023 session
26
1. The result of the above listed National Entrance Tests must have been declared between July 2021 and last date of application i.e. 16.08.2023).
2. The award of the fellowship must be based on the result of the above listed National Entrance Tests
3. The fellowships should be tenable at AIIMS, New Delhi
4. The letter of award of fellowship must be uploaded with the application form. Passing of the listed National Entrance Tests is not acceptable as proof of award of fellowship.
3. STAGE III:
After combining the marks of Stages I, II and special weightage (detailed in points 1 and 2 above), three (03) times as many candidates as the number of seats advertised in a department will be called for departmental clinical/practical/lab based assessment (carrying 20 marks).These marks will be added to the marks of stages I + II + special weightage to determine the final total marks.
4. FINAL RESULT:
Candidates who secure 50% marks in Stage-I, II (including special weightage) & III Combined (50/100) shall be eligible for admission and shall be included in the final merit list. If a candidate is awarded special weightage marks based on submitted documents that are subsequently found to be ineligible, the special weightage marks awarded will be withdrawn and the final result will be recalculated.
5. PROCESS OF SEAT ALLOCATION
a) All seats in a department will be clubbed.
b) Candidates will be eligible ONLY for seats in the department that they have applied for.
c) Candidates will be allotted seats in order of their merit in the entrance examination.
d) Candidates WITH their Own Government Fellowship (OF) can select from both OF and Fellowship Available (FA) seats (where they fulfill the eligibility criteria for the seat)
e) Candidates WITHOUT their Own Government Fellowship can select only Fellowship Available (FA) seats (where they fulfill the eligibility criteria for the seat)
f) Candidates who are allotted a seat but do not join or resign after joining will not be eligible for any additional rounds of seat allocation.
B: Examination will be conducted through online (CBT) modes in Delhi/NCR only.
C: Evaluation Procedure of Stage I & II
Each correct (MCQ) answer will be awarded 1 mark and each wrong (MCQ) answer will be awarded onethird (-1/3) negative mark. More than one answer will be treated as wrong answer and awarded negative mark. Zero mark will be given for questions not answered or marked for review.
• Each correct response will get a score of 1 mark.
• Each incorrect response will get a score of - 1⁄3 (minus-one-third).
• No credit will be given for the questions not answered or marked for review.
Ph.D. Prospectus for July, 2023 session
27
CORRECT WRONG FOR REVIEW NOT ANSWERED +1 - ⅓ 0 0
If any discrepancy in any question is found in the Entrance Examination, the candidate is advised to write to Associate Dean (Exam), AIIMS, New Delhi – 110 608 within 24 hours on the following email: E-mail subdeanexamsaiims@hotmail.com. This mail will only be used for discrepancy related to question. However, for other query login with your credentials and click on “Queries” link available on MYPAGE.
Note:
I) The combined result of Stage-I & stage-II will be available on website of the Examination Section, AIIMS and on website. No individual intimation will be communicated to the candidate.
II) Candidates who fail to attend any of the stages of examinations as mentioned above will not be eligible for admission.
III) Admission to Ph.D. Course will be subject to the availability of research funds/fellowship/ grant from recognized funding agencies. After declaration of results, selection letters will be issued by the Academic Section only to those candidates who have submitted Undertaking/Proof of their funding sources through concerned Head of the Departments
D: Method of Resolving Ties
The tie cases will be resolved according to age (Date of birth), the older candidate shall get preference over the younger one.
E: Joining
Selected candidates are required to join as per the date given in his/her provisional offer letter. In case the candidate is not granted an extension for joining and fails to join by the date given to him/her in provisional offer letter, it will be assumed that he/she does not intend to join the course and the seat will be offered to the next candidate on the waiting list. No further correspondence will be entertained in this regard.
IMPORTANT
The PhD Seats shall lapse if the selected candidates do not join by 16th October, 2023 for July session. No candidate shall be allowed to join after 16th October, 2023 for July session.
F. RULES FOR ADMISSION FOR IN-SERVICE CANDIDATES – (NONMEDICAL) APPLICABLE FOR AIIMSEMPLOYEES ONLY
Theindividualshouldbea regularemployeeofthe Institute (AIIMSNewDelhi)andshouldhaverendered a minimum of five years of continuous service at the institute.
He/She should fulfil all the eligibility criteria for the Ph.D. course, and will appear in the entrance examination and must score minimum of 50% marks.
The individual should have 5 years of active service remaining in the institute.
The candidate should have a proven track record of active involvement in research / academic activities of the department. He/she should possess good written and verbal communication skills in English language to be certified by HOD/Chief of Center.
Ph.D. Prospectus for July, 2023 session
28
The candidate should have at least 3 original research publications (not case reports) during the last three years immediately preceding the date of his/her application either as a first author or as a communicating author in a peer reviewed journal.
The candidate will be considered as in-service candidate provided that the Head of the Department should certify that the work of the department will not suffer and no additional staff will be asked for.
The candidate seeking admission under this category will have to identify a faculty member in the Institute who is willing to be the chief-guide of the candidate. The candidate should submit a letter of acceptance/undertaking from the concerned faculty member in this regard.
G. LEAVES AND OTHER RULES
The Ph.D. students are entitled for 30 days leave every year, if leave availed exceed the limit within a year, then the extended period is treated as Extra Ordinary Leave and his/her minimum registration will be extended for the same duration.
However, extraordinary leave cannot be more than 3 months in the entire registration period of 5 years. Any such extension beyond 3 months shall lead to the registration being cancelled. The female candidates shall be entitled for maternity leave etc. as per existing rules.
In case the Chief Guide recommends a candidate for specific training or project related work outside AIIMS (within India or abroad), the leaves shall be treated as on duty/Study leave. This study leave shall not be more than 6 months in the entire registration period. The proof of acceptance of the candidate for such training/work outside should be submitted and on return, the report of such training/work done shall be required to be submitted to the Dean, by the candidate through the chief guide
Ph.D. Prospectus for July, 2023 session
29
1. INSTRUCTIONS FOR FILLING THE ONLINE APPLICATION FORM
CandidateshouldfillintheOnlineApplicationFormtakingutmostcareandfollowtheinstructionsandhelpmanual as given in the APPENDIX - II of the Prospectus, step by step. Candidate should fill in the Online Application form correctly. Incorrect filled form may lead to rejection.
2. ONLINE REGISTRATION & SUBMISSION OF APPLICATION FORM
Acandidateseeking admissiontothe Entrance Examination is required to submit his/her application inthe prescribed format availableonlinewith the Prospectus onwww.aiimsexams.ac.in. ThecostofApplicationFormincludes thefee for entrance examination which is non-refundable and no correspondence in this regard will be entertained. The candidate is required to go through the Prospectus carefully and acquaint himself/herself with all requirements with regard to filling of the online application form.
Online Registration: After selecting the online registration, fill the mandatory details asked for and deposit the prescribed fee through debit/credit card/Net Banking. After submitting fees filled required information step by step. Follow the Instructions scrupulously.
It will be the responsibility of the candidates to ensure that correct details are filled in the Registration Form. The Institutewillnot be responsible for any incorrect information/cancellation of candidature/loss or lack of communication etc. due to wrong filled online Application form.
No candidate should register more than three (3) applications. All applicants are required to ensure that Photo/Signature/Left Thumb Impression is uploaded according to the instructions provided in the Prospectus. Failure to do so may result in rejection of applications. Duplicate applications from any applicant will result in cancellation of all such applications. No intimation regarding such summary rejections will be provided.
3. STATUS OF ONLINE REGISTRATION
Acknowledgement of successful Online Registration will be forwarded to applicant’s Registered Email ID. The Registration Form will remain Under Review regarding uploaded images and eligibility. However, candidates can check their status of uploaded images within two working days from the date of online Registration is done and subsequent further status updates. The rejected images can be updated till the registration is open.
The candidates are advised to check finalstatus of their Registration Form regarding images and eligibility and Admit Card which will be available on AIIMS website as per the schedule mentioned in the “IMPORTANT DATES AT A GLANCE”.
Admit Card for Accepted Registration Form will only be uploaded on the website. If the status of Registration Form or Admit Card is not available on website, he/she should immediately write an email to the Assistant Controller of Examinations, AIIMS, New Delhi-110608 OR login with your credentials and click on “Queries” link available on MYPAGE.
4. DOCUMENTS TO BE ATTACHED WITH REGISTRATION FORM
I) No document is required, except the following applicability:
(i) Sponsored Candidates and Foreign nationals.
1) Sponsorship Certificate (in the case of sponsored candidate) in the format prescribed in the Prospectus, duly completed and signed by the competent authority.
2) NOC from Ministry of Health & Family Welfare in case of Foreign National.
Note: Sponsored/Foreign national category candidates should send the above documents in a separate envelope to the Asstt. Controller (Examinations), Examination Section, AIIMS, Ansari Nagar, New Delhi – 110608 indicating their Registration No. on the top of the envelope and on the documents followed by the name of course/discipline applied for.
(ii) Proof of award of eligible fellowship for non-medical candidates applying in OF category
(iii) Candidates who qualify in Stage I and II and are called for Departmental Assessment must upload their self attested/attestedcopiesofcertificates/documentsinsupportoftheireducationalqualifications,marks,date of birth, category, experience etc. as mentioned inthe Stage-I and II resulton the website by logging in with their
30
Ph.D. Prospectus for July, 2023 session
V
IMPORTANTINSTRUCTIONAPPLICABLETOPh.D.PROGRAMMEEXAMINATION
credentials. They must write their Candidate ID, Roll No. & concerned Department on the top of first page of each certificate.
If a candidatefails to submit attested copiesof therequisitedocumentsasabove, his/hercandidature will be cancelled and he/she will not be allowed to participate in subsequent stages of selection/admission process.
5. SUBMISSION OF APPLICATION BY CANDIDATES WHO ARE EMPLOYED
The candidates in employment applies for Ph.D. Program are required to submit their applications through proper channel. They should also sign the undertaking in the down loaded copy of Registration Form that they have informed their employer about the submission of the application to AIIMS. If any communication is received from theirdepartment/officewithholdingpermissiontothecandidate'sappearingattheentranceexamination/admission tothecourse, thecandidature/admission of the candidatewill be cancelled, and no further correspondence in this regard will be entertained. (Sponsored candidates for Ph.D. Programare required to route their Registration Form through proper channel).
6. REQUIREMENTS FOR ADMISSION OF "SPONSORED" CANDIDATES
a) Candidates who are permanent employees of any Central/State Government/Armed Forces or the Public Sector Undertaking/Autonomous Body can be sponsored by the respective Government/Defence Authorities or the Competent Authorities of PSU/Autonomous Body.
b) All eligible "sponsored" candidates will be called by the Institute for an entrance test.
c) Seats as shown in the prospectus are available for "sponsored" candidates. Sponsored candidates will be designated as "trainees".
d) The subject for which thecandidate is being sponsoredshould beclearly specified inthe sponsorship form by the sponsoringauthority.Thecandidatecanbesponsoredforonlyonesubject.Theapplicationsofthosecandidates who are sponsored for more than one subject will not be considered.
e) No"Sponsored"candidatewillbepaidanyemolumentsbytheInstituteduringthetrainingperiod.Suchpayments will be the responsibility of the sponsoring authority (i.e. Central/State Government or Defense Authorities).
f) Sponsoredcandidatesmustsubmit/send fromtheiremployersinthefollowing formatalongwiththeapplicationformtotheAsstt.Controller(Examinations),AIIMS,AnsariNagar,NewDelhi110029. Those who failto do so should submit it before the date of issue of Admit Cards as mentioned under "AT A GLANCE" in the Prospectus failing which their candidature will be cancelled.
7. REQUIREMENTS FOR ADMISSION OF FOREIGN NATIONALS/OVERSEAS CITIZEN OF INDIA (OCI)
a) Foreign nationals are required to fill in the prescribed online application form indicating the choice of subject for admission to Postgraduate courses leading to award of Ph.D. Program degree.
b) The foreign nationals are required to send their Registration Form of Online application through Diplomatic Channel.TheyarealsorequiredtoappearintheCompetitiveEntranceExaminationalongwithothercandidates. An ‘AdvanceCopy’tobe submitted at AIIMS,NewDelhibeforethe lastdate of onlineregistration. However,the application of all such candidates willbe processed only after receipt of the same through Diplomatic Channel.
c) The foreign nationals will be considered against the seats advertised under the "Sponsored" category for Ph.D. Program. They should be registered with MCI before they will be allowed to join the said course. If they are selected for the same.
d) Seats are not reserved in any discipline for foreign nationals (except the bilateral agreement between the Government of India and any other nation).
e) Nominations/NoobjectionforthecandidateshouldreachtheExaminationSectionbeforethedateofissueofthe AdmitCardasspecifiedunder"ATAGLANCE".Incaseofnon-receiptofthenominations/clearance/noobjection from the concerned Ministry by due date, their candidature will not be considered.
f) No emoluments will be paid by AIIMS to the Foreign National candidates.
g) OVERSEASCITIZENOFINDIA(OCI): OCIregisteredunderSection7AofCitizenshipAct1955arealsoeligible to appear in PG courses and all terms and conditions applicable for Indian Nationals will be applicable to the candidates. The candidate will submit proof of Registration as OCI under Section 7A of Citizenship Act 1955 to be eligible to appear for this test.
8. PROCEDURE FOR REDRESAL OF DISCREPANCY NOTICED:
(i) If any discrepancy in any question is found in the Entrance Examination, the candidate is advised to write to
31
Ph.D. Prospectus for July, 2023 session
Associate-Dean (Exams),AIIMS, New Delhi–110608 within 24 hours onsubdeanexamsaiims@hotmail.com. (ii) Discrepancy, if any, in the Prospectus, Admit Card etc. should be immediately brought to the notice of the Assistant Controller (Examinations) AIIMS, New Delhi by login with your credentials and click on “Queries” link available on MYPAGE. Complaints received after the examination will not be entertained.
9. Itwillbetheresponsibilityofthecandidatetoensurethatcorrectaddress,MobileNo.&emailIDintheApplication Form is filled. The Institute shall not be responsible for any miscommunication due to incorrect address, Mobile No. and email ID given by the applicant on the Application Form or non-receipt for any communication.
10. Downloadable Admit cardsof allthe eligiblecandidates will behosted on websitewww.aiimsexams.ac.in as per the schedule mentioned under ‘AT A GLANCE’. All the candidates are advised to download their Admit Cards from the website. It may please be noted that the Admit Cards will not be sent by Post.
11. Any Change in the address mobile No. and email ID should be immediately intimated to this office by registered mail Candidate should also ensure that any communication sent at the previous address is redirected to him/her at the new address.
12. If a candidate is at any stage found to have provided false information/certificate or is found to have withheld or concealedsomeinformationinhis/herapplicationform,he/shewillbedebarredfromadmission,his/herresidency will be terminated with immediate effect.
13. Ifineligibilityisdetectedatanystage,candidature/admissionofthecandidatewillbecancelledwithoutanynotice.
14. Candidate must not obtain or give or attempt to obtain or give irregular assistance of any kind during the examination; this will entail expulsion and cancellation of candidature for the examination. The admission of the candidatewillbecancelled and appropriatecriminal/civilproceedingswillbeinitiatedagainstthecandidates,ifat any stage of the examination the candidate is found to have secured admission by using any unfair means.
15. The Institute will not intimate the result of Entrance Test individual. No correspondence in this regard will be entertained. However, the marks of individual candidate will be made available on AIIMS website www.aiimsexams.ac.in
16. There is no provision for re-checking/re-evaluation of the answer sheets and no query in this regard will be entertained.
17. The decision of the Director of the Institute shall be final in the matter of selection of candidates for admission to Ph.D. Program and no appeal will be entertained in this regard.
18. Selected candidates must join the course on the date stipulated in the letter of selection, failing which the selection/admission shall stand cancelled/withdrawn.
19. The selected candidates will have to submit the original Permanent Registration Certificate at the time of joining.
20. The selection of students in Ph.D. Program will be subject to medical fitness. No selected candidate will be permittedtopayfee/jointhecourseunlessdeclaredmedicallyfitbytheMedicalBoardappointedby theInstitute. The decision of the Medical Board shall be final.
21. Each candidate selected for admission shall have to pay the fee/dues within the prescribed period failing which his/her admission shall be cancelled.
22. Private practice in any form during the course is prohibited. The period of training is strictly full time and continuous.
23. The rules are subject to change in accordance with the decision of the Institute to be taken from time to time.
24. Any dispute in regard to any matter referred to herein shall be subject to the jurisdiction of Delhi Courts alone.
25. SUBMISSION OFCASTECERTIFICATEBYSC/ST/OBCCANDIDATES
After declaration of result of the Entrance Examination, candidates belong to Scheduled Caste/Scheduled Tribe and Other Backward Classes should submit, along with other requisite documents, an attested copy ofacertificatefromanyoneofthefollowingauthoritiesstatingthatthecandidatebelongstoScheduled
32 Ph.D.
Prospectus for July, 2023 session
Information Page
After re-login the next page appears will page will show the all Seven (7) steps of Registration Process. First step is new candidate Registration for Ph.D. July 2023 Session.
The color of the Number of the Step in Navigation Bar will change from Red to Yellow as the steps get completed and candidate can jump/go to any steps among the completed steps at any time.
Color will change from Red to Yellow as a step of registration gets completed
43 Ph.D. Prospectus for July, 2023 session
iii) Edit Information Page
Candidate should re-check the filled in information, in case there is some error in the information filled in the form Candidate can edit some information by clicking on Registration Yellow Wizard. It will redirect candidate to Registration page where some information can be edited.
After click on Update button, Candidate will be navigated to Candidate Dashboard Page.
44 Ph.D. Prospectus for July, 2023 session
Step 2: Qualification Details
After first step of registration process is completed, the next step is to fill Qualification Details. Candidate should fill all the information asked for regarding Qualifying Examination, Internship and Medical Registration. After fill all required filled then click on Save and Proceed button.
45 Ph.D. Prospectus for July, 2023 session
Click on Save and Proceed Button to fill Experience Details.
Step 3: Experience Details
After fill the Qualification Details, next step is Experience Details. Candidate has to fill requirement details related to Experience as desired according to the course applied for.
46 Ph.D. Prospectus
for July, 2023 session
Step 4: City Choice
The Fourth step is City Choice. After filling Experience details candidate will be directed to City Choice Page
47 Ph.D. Prospectus for
July, 2023 session
Click on Proceed button for payment of Registration Fee.
Step 5: Make Payment
After Centre Choice, candidates will be navigated to Payment page to make payment of registration Fee. Payment of registration fee can only be done through Online Mode i.e. Debit/Credit card and Internet Banking.
Loginwithyourcredentialsofnetbankingforfeepayment, andclickonsubmitbuttontoproceedforpayment.
48 Ph.D. Prospectus for July, 2023 session
Candidate should enter the information asked for to pay through on line mode and click on PAY button.
Candidate must remember to take printout of Payment Receipt as a proof of payment by clicking on Print button.
49 Ph.D. Prospectus for July, 2023 session
Step 6: Upload Images
After Successful Payment Confirmation, Candidate needs to upload their latest passport size Photograph, Signature and Thumb Impression. The supported digital image format includes gif, png, jpg/jpeg. Upload Images
First read the instructions given regarding Photo, Signature and Thumb Impression upload. To upload image click Choose File button and browse to path where the image is stored. You can see the preview of the uploaded images. Please refer to Sample Images provided on the page, if you are satisfied with the preview of images, click on Accept button else try again to upload the images. After uploading all three required images, give consent on
50 Ph.D. Prospectus for July, 2023 session
the declaration and click on Save & Proceed button. Images once uploaded cannot be changed later so candidates are requested to pay due attention while uploading the images.
Step 7: Print Registration Form
The seventh and the Last Step is Print Registration Form. Candidate must take print of Registration Slip once all steps of registration are completed. Click on Submit button and take printout of Registration Form.
Registration Form contains all the details provided by candidate during on line registration i.e. Personal Details, Qualification Details, Experience Details, Payment details and Uploaded Images etc.
51 Ph.D. Prospectus for July, 2023 session
Check all the details in Registration Form carefully, if some entered information is to be corrected/ edited then click on edit button, do the necessary corrections and then click on Final Submit button.
for July, 2023 session
52 Ph.D. Prospectus
the print of
submission
form. Candidate can take the print out of
Registration
Take
the Registration Slip after final
of
the
Form by clicking on Print button
After clicking Final Submit button, color of navigation bar of all the steps of registration process will change to Yellow from Red.
After completing all 7 steps of registration candidate will be registered successfully and can navigate to any completed step through Navigation Buttons available on top of the page. Candidate should Logout after registration is done successfully.
53 Ph.D.
Prospectus for July, 2023 session
Candidates are required to upload their Photograph, Signature and Left Thumb ImpressionduringOnlineRegistration.
Instructionforphotoupload
PHOTOGRAPH:
1. One (1) recent color passport size photograph (should not be more than “six months old” from the date of registration)with whitebackground is required. The dimensions of the photograph should be 3.5*4.5 cms (width*height).
2. Black & White / Polaroid photographs are NOT acceptable. Photograph should not be taken by mobile phone camera.
3. Photograph should betaken professionally, so that it may not blur while enlarging it.
4. Photograph MUST be taken recently and should not be taken more than six months prior from the start of Online Registration.
5. Draw a box having size 3.5 x 4.5 cms (width*height) on a plain white sheet and paste the photograph inside the box.
6. Select the area having photograph only, not the whole sheet and scan the photograph on 200 dpi.
7. Save the scanned image as “Photograph.jpg" (supported formats include jpg/ jpeg, gif,png). Keep the size of image between 10KB to 100 KB.
UPLOADINGPHOTOGRAPH:
Candidates must upload Photograph to correct specified field. Do not make any mistake in uploading Photograph
1. To upload "Photograph.jpg"
a. Click "Choose File" button right to the photograph field.
b. Select the scanned "Photograph.jpg" file from saved location and click "Open" button.
54
Ph.D. Prospectus for July, 2023 session
IX
INSTRUCTIONFORUPLOADINGIMAGES
While uploading images during Online Registration, please refer following Not Acceptable/Acceptable sample images.
Ph.D. Prospectus for July, 2023 session
55
56 Ph.D. Prospectus for July, 2023 session
SIGNATURE:
1. Draw a box of size 6 x 3 cms (width * height), on a plain white sheet and put the signature inside the box.
2. Signature should be done with thick point Black/Blue pen only. Signatures having only Initials or done in CAPITAL letters are not acceptable.
3. Scan the area having signature only not the whole sheet Scan the signature on 200 dpi. It should not be blurred while enlarging it.
4. Save the scanned image as "Signature.jpg". Supported formats of the image include jpg/jpeg, gif, png.Keep the size of the image between 10 KBto50KB.
57 Ph.D. Prospectus for July, 2023 session
UPLOADINGSIGNATURE:
Candidatesmustupload Signaturetocorrectspecified field.Donotmakeanymistake inuploadingSignature.
1. To upload "Candidate Signature.jpg"
a. Click “Choose file” button right to the signature field.
b. Select the scanned "Signature.jpg" file from saved location and click "Open" button
While uploading Signature during Online Registration, please refer following Not Acceptable/Acceptable sampleSignatureimages.
Signature
Signature
Signature
Signature
Signature
Signature
Signature
Properly uploaded signature that is in black with white background. The signature is clear and of proper size.
NOT ACCEPTABLE: Signature uploaded is very small
NOT ACCEPTABLE: Signature is in coloured ink
NOT ACCEPTABLE: Signature uploaded is too light and unclear
NOT ACCEPTABLE: Signature uploaded alongwith background
NOT ACCEPTABLE: Signature uploaded is partly obscured by marks / sprinkled ink
NOT ACCEPTABLE: Signature uploaded is blurred
NOT ACCEPTABLE: Signature is cropped / not scanned properly
58 Ph.D. Prospectus for July, 2023 session
LEFTTHUMB IMPRESSION:
1. Draw a box of size 4x 3cms (width * height) on a plain white sheet.
2. Take a good quality Blue/Black ink stamp pad.
3. Put your left thumb gently on the stamp pad and role lightly in horizontal manner.
4. The lines of the finger should be clearly visible in the print.
5. Scan the area of white sheet having thumb impression only, not thewhole sheet.
6. Scan the left thumb impression on 200 dpi. It should not be blurred while enlarging it.
7. Save the image as "Left Thumb Impression.jpg". Supported formats of the image include jpg/jpeg, gif, png.
8. Keep the size of image between 10 KBto50KB.
UPLOADINGLEFTTHUMBIMPRESSION:
Candidates must upload Left Thumb Impression to correct specified field. Do not make any mistake in uploading Left Thumb Impression.
1. To upload "CandidateLeftThumbImpression.jpg"
a. Click “Choose file” button right to the Left Thumb Impression field.
b. Select the scanned " " file from saved location and click "Open
While uploading Left Thumb Impression during Online Registration, please refer followingNotAcceptable/Acceptablesample LeftThumbImpressionimages.
Properly uploaded Left Thumb Impression in .jpg. The Left Thumb Impression is clear and of proper size.
NOT ACCEPTABLE: Left Thumb Impression Left Thumb Impression uploaded is blurred.
NOT ACCEPTABLE: Left Thumb Impression uploaded is partly obscured by too much ink.
NOT ACCEPTABLE: Left Thumb Impression uploaded is partly cropped / not scanned completely
59 Ph.D.
Prospectus for July, 2023 session
1. I certify that Dr./Miss/Mrs./Mr.* ______________________________ is being sponsored fortrainingleadingtotheawardofPh.D.Programmein_______________________atAll India Institute of Medical Sciences forthe session commencing in July, 2023.
2. ThatDr./Miss/Mrs./Mr.*______________________________isapermanentemployeeof _______________________ (name of the State/Central Govt. Dept./Office/Armed Forces/the Competent Authorities of PSU/Autonomous Body etc.)
3. That Post Graduate[Ph.D. Programme] course for which the candidate is being sponsored.
4. That he/she after getting the training at the AIIMS will be suitably employed by the sponsoring authority in the specialty in which training is to be provided in AllIndia Institute of MedicalSciences.
5. Thatthecandidatewillbepaidallemolumentsbythesponsoringauthorityduringtheentire training period. Such payment will not be the responsibility of the All India Institute of Medical Sciences.
6. That the candidate is being sponsored for the entire duration of the course as specified in the prospectus for the above mentioned course.
Date:_____________
Place:___________
Office Seal _____________________________
*Delete whichever is not required.
IMPORTANT:
(i) The above certificate, duly signed only by the Competent Authority i.e. Secretary/Director General of Health Services of the Central/State Government concerned/DGAFMS/Director/ExecutiveHead,will beconsidered.
(ii) No addition or alteration in the above certificate is allowed.
(iii) Subject/Discipline must be specified in the sponsorship certificate failing which the candidature will not be considered underthe sponsored category.
NOTE-1:Whilesponsoring the candidates,the Central/StateGovernment/DefenceAuthorities /PSU/ Autonomous Bodies should furnish a certificate prescribed for this purpose duly completed and signed by the competent authority.
NOTE-2: The 'Sponsorship Certificate' shouldindicate the discipline/specialty for which the candidate is being sponsored, failing which the application willnot be considered under the Sponsored Category.
60 Ph.D.
Prospectus for July, 2023 session
Signatureof_____________________________
Name__________________________________
Designation____________________________
FORMATOFSPONSORSHIPCERTIFICATEBYCENTRAL/STATEGOVT./ARMEDFORCES (SPONSORINGAUTHORITIES)
PROFORMA FOR OTHER BACKWARD CLASS (OBC) CERTIFICATE
(Certificate to be Produced by other Backward Classes applying for Admission to Central Educational Institutions (CEIs), Under The Government of India)
This is to certify that Shri /Smt./Kum.__________________________________________________Son/Daughter of Shri/Smt.______________________________of Village/Town__________________District/Division_______ in the ____________________________State belongs to the _______________________Community which is recognized as a backward class under:
(i) Resolution No. 12011/68/93-BCC(C) dated 10/09/93 published in the Gazette of India Extraordinary part I Section I No. 186 dated 13/09/93.
(ii) Resolution No. 12011/9/94-BCC dated 19/10/94-BCC dated 19/10/94 published in the Gazette of India Extraordinary part I Section I No. 163 dated 20/10/94.
(iii) Resolution No. 12011/7/95-BCC dated 24/05/95 published in the Gazette of India Extraordinary part I Section I dated 25/05/95.
(iv) Resolution No. 12011/96/94-BCC dated 09/03/96.
(v) Resolution No. 12011/44/94-BCC dated 06/12/96 published in the Gazette of India Extraordinary part I Section I No. 210 dated 11/12/96.
(vi) Resolution No. 12011/13/97-BCC dated 03/12/97.
(vii) Resolution No. 12011/99/94-BCC dated 11/12/97.
(viii) Resolution No. 12011/68/98-BCC dated 27/10/99.
(ix) Resolution No. 12011/88/99-BCC dated 06/12/99 published in the Gazette of India Extraordinary Part I Section I No. 270 dated 06/12/99.
(x) Resolution No. 12011/36/99-BCC dated 04/04/2000 published in the Gazette of India Extraordinary Part I Section I No. 71 dated 04/04/2000.
(xi) Resolution No. 12011/44/99 BCC dated 21/09/2000 published in the Gazette of India Extraordinary Part I Section 1 No. 210 dated 21/09/2000.
(xii) Resolution No. 12015/09/2000
(xiii) Resolution No. 12011/01/2001
(xiv) Resolution No. 12011/04/2002
(xv) Resolution No.12011/09/2004-BCC dated 16/01/2006 published in the Gazette of IndiaExtraordinary Part I Section I No. 210 dated 16/01/2006.
Shri/Smt./Kum. _________________________and/or his family ordinarily reside(s) in the__________________________ District/Division of ___________________________ State. This is also to certify that he/she does not belong to the persons/sections (Creamy Layer) mentioned in Column 3 of the Scheduled to the Government of India. Department of Personnel & Training O.M. No. 36012/22/93-Estt. (SCT ) dated08/09/93 whichis modified vide OMNo. 36033/3/2004 Estt. (Res.) dated 09/03/2004 or the latest notification of the Government of India.
Dated :
NOTE:
District Magistrate/Competent Authority Seal
(a)The Term Ordinarily used here will have the same meaning as in Section 20 of the Representation of the People Act, 1950.
(b) The authorities competent to issue Caste Certificates are indicated below:
(i) District Magistrate/Additional Magistrate/Collector/Deputy Commissioner/Additional Deputy Commissioner/Deputy Collector/Ist Class Stipendiary Magistrate/Sub-Divisional Magistrate/Taluka Magistrate/Executive Magistrate/Extra Assistant Commissioner (not below the rank of Ist Class Stipendiary Magistrate.)
(ii) Chief Presidency Magistrate/Additional Chief Presidency Magistrate/Presidency Magistrate.
(iii) Revenue Officer not below the rank of Tehsildar.
(iv) Sub-Divisional Officer of the area where the candidate and/or his family resides.
61 Ph.D.
Prospectus for July, 2023 session
FORM OF SC/ST CERTIFICATE PRESCRIBED
Form of certificate as prescribed in M.H.A., O.M., No. 42/21/49-N.G.S. dated the 28.1.1952, as revised in Dept. of Per-& A.R. letter No. 36012/6/76-Est. (S.CT), dated the 29.10.1977, to be produced by candidate belonging to a Scheduled Caste or a Scheduled Tribe in support of his/her claim.
CASTE CERTIFICATE
This is to certify that Shri/Smt./Kum.*.............................................................. son/daughter*of................................of village/town*........................................in district/Division*..............................of the State/Union Territory* ................................................ belongs to the...............................Caste/Tribe which is recognised as a Scheduled Caste/Scheduled Tribe*under:
TheConstitution(ScheduledCaste)Order,1950
TheConstitution(ScheduledTribe)Order,1950
TheConstitution(ScheduledCaste)(UnionTerritories)Order,1951
TheConstitution(ScheduledTribe)(UnionTerritories)Order,1951
% 1. (as amended by the Scheduled Caste and Scheduled Tribes Lists (Modification) Order, 1956, the Bombay Reorganization Act, 1960, thePunjabRe-organizationAct, 1966, theStateofHimachal Pradesh Act, 1970theNorth Eastern Areas (Re-organization) Act, 1971 and the Scheduled Castes and Scheduled Tribes Orders, (Amendment) Act, 1976). The Constitution(JammuandKashmir)ScheduledCasteOrder, 1956.
TheConstitution(AndamanandNicobarIslands)ScheduledTribesOrder,1959.
TheConstitution(DadraandNagarHaveli)ScheduledCasteOrder,1962.
TheConstitution(DadraandNagarHaveli)ScheduledTribesOrder,1962.
TheConstitution(Pondichery)ScheduledCasteOrder,1964
TheConstitution(UttarPradesh)(ScheduledTribes)Order,1967
TheConstitution(Goa,Daman&Diu)ScheduledCasteOrder,1968.
TheConstitution(Goa,Daman&Diu)ScheduledTribesOrder,1968.
TheConstitution(Nagaland)ScheduledTribesOrder,1970.
TheConstitution(Sikkim)ScheduledCasteOrder,1978.
TheConstitution(Sikkim)ScheduledTribesOrder,1978.
%2.ApplicableinthecaseofScheduledCaste/ScheduleTribepersonswhohavemigratedfromoneState/UnionTerritory Administration:
This certificate is issued on the basis of the Scheduled Caste/Scheduled Tribe certificate issued to Shri/ Smt.*...................................father/motherof Shri/Smt./Kum*...........................of village/town*...................... in District/Division*oftheState/UnionTerritory*........................whobelongstothe...............caste/tribewhichisrecognised as a Scheduled Caste/Scheduled Tribe* in the State/UnionTerritory* ......................... issued by the (name of prescribed authority) vide their No.................date.......... % 3. Shri*/Smt.*/Kum* ........................... and/or his/her* family ordinaryreside(s)invillage/town*.....................oftheState/UnionTerritoryof......................
Signature............................
Place.......................
Date.......................
Please delete the words which are not applicable.
Please quote specific Presidential Order.
% Delete the paragraph which is not applicable.
** Should be signed by the Authorities empowered to issue Scheduled Caste/Scheduled Tribe certificates as specified above.
62 Ph.D. Prospectus for July, 2023 session
State/UnionTerritory **Designation............................
(WithsealofOffice)
Note: Must be issued between dates as Important Notice under Important Dates at a Glance
63 Ph.D. Prospectus for July, 2023 session
Note: -
The information will appear in the website strictly as per time schedule laid down in the Prospectus. Telephonic queries / written requests prior to the scheduled date mentioned in the Prospectus regarding receipt of application, acceptance, hoisting of admit cards etc. will not be entertained.
For enquiries relating to Entrance Examination please contact: Assistant Controller (Exams) Examination Section
All India Institute of Medical Sciences (AIIMS)
Ansari Nagar, New Delhi -110 608
Tel: 26589900, 26588500 Extn. 6421, 4499, 6422
Fax: 011 2658 8789
DISCLAIMER
The prospectus is a compilation of information obtained and collated from Examination and Academic Sections of AIIMS, New Delhi, other new AIIMS and related sources. Due care has been taken to faithfully reproduce the information provided by various sources.
The AIIMS, New Delhi disclaims any liability towards any individual or group of individuals for any loss or damages caused due to him/her arising out of any action taken on the basis of any information contained in this prospectus that may be due to inadvertent omissions or errors or for any other reason whatsoever.
The AIIMS, New Delhi reserves the right to suitably modify, update or delete or add any part of the prospectus as may be considered necessary by the competent authorities.
64 Ph.D. Prospectus for July, 2023 session